Researchers Continue Treating Patients Amid Pandemic, Other COVID-19 News
This week saw the clinical research community make a concerted effort to continue treating patients amid the COVID-19 pandemic. Researchers have outlined recommendations for the treatment of bladder cancer during the COVID-19 pandemic.
Important
Researchers Continue Treating Patients Amid Pandemic, Other COVID-19 News
This week saw the clinical research community make a concerted effort to continue treating patients amid the COVID-19 pandemic. Researchers have outlined recommendations for the treatment of bladder cancer during the COVID-19 pandemic.
Important
Study Finds Not Enough Women, Older Adults In Cholesterol Trials
After analyzing the trends in the types of 485,409 people enrolled in 60 studies from 1990 to 2018, Johns Hopkins Medicine researchers report that, although some progress has been made, women and older adults are still vastly underrepresented in lipid lowering therapy trials compared with their disease burden.
Study Finds Not Enough Women, Older Adults In Cholesterol Trials
After analyzing the trends in the types of 485,409 people enrolled in 60 studies from 1990 to 2018, Johns Hopkins Medicine researchers report that, although some progress has been made, women and older adults are still vastly underrepresented in lipid lowering therapy trials compared with their disease burden.
Zhittya gets regulatory approval in Mexico for trial of drug in PD patients
Zhittya Genesis Medicine has secured regulatory approval from Mexico’s governing body COFEPRIS to test its drug in people with Parkinson’s disease (PD).
Zhittya gets regulatory approval in Mexico for trial of drug in PD patients
Zhittya Genesis Medicine has secured regulatory approval from Mexico’s governing body COFEPRIS to test its drug in people with Parkinson’s disease (PD).
Trials Reveal New Understanding of COVID-19, And Other News
Researchers have found that COVID-19 patients have a high predisposition to developing blood clots. Elsewhere, teams develop a COVID-19 trial finder. We round up the week’s research and industry news for COVID-19.
Trials Reveal New Understanding of COVID-19, And Other News
Researchers have found that COVID-19 patients have a high predisposition to developing blood clots. Elsewhere, teams develop a COVID-19 trial finder. We round up the week’s research and industry news for COVID-19.
Mexican Hospital Starts Clinical Trial Testing Ivermectin in Serious, Non-Critical Hospitalized COVID-19 Patients
The sponsor, a hospital in central Mexico, seeks to investigate the safety and efficacy of a treatment involving hydroxychloroquine and ivermectin for serious COVID-19 infections in non-critical hospitalized patients.
Mexican Hospital Starts Clinical Trial Testing Ivermectin in Serious, Non-Critical Hospitalized COVID-19 Patients
The sponsor, a hospital in central Mexico, seeks to investigate the safety and efficacy of a treatment involving hydroxychloroquine and ivermectin for serious COVID-19 infections in non-critical hospitalized patients.
IRT: A competitive advantage to accelerate clinical trials during a global pandemic and beyond
Interactive Response Technology (IRT) can serve many different functions in clinical research, from patient randomisation to making data-driven calculations for patient dosing. B
IRT: A competitive advantage to accelerate clinical trials during a global pandemic and beyond
Interactive Response Technology (IRT) can serve many different functions in clinical research, from patient randomisation to making data-driven calculations for patient dosing. B